Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion type Assertion NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_head.
- NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion description "[The aim of our study was to evaluate the effect of KIR genes and KIR ligands on leukemia free survival (LFS) and relapse rate in a well-defined, homogeneous group of CML patients phase upon HLA identical sibling SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_provenance.
- NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion evidence source_evidence_literature NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_provenance.
- NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion SIO_000772 18555529 NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_provenance.
- NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion wasDerivedFrom befree-20140225 NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_provenance.
- NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_assertion wasGeneratedBy ECO_0000203 NP860347.RArP19BV6nxWDD_Exkku8JSAyEUNyvJTdWbqF7grajcO4130_provenance.